StonvexLoading…
StonvexStonvexStonvexCore line items from OVID's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.25M | $566.00K | $392.00K | $1.50M |
Operating Income | $-42.44M | $-61.88M | $-59.28M | $-55.55M |
Net Income | $-17.41M | $-26.43M | $-52.34M | $-54.17M |
EPS (Diluted) | Not available | Not available | $-0.74 | $-0.77 |
Total Assets | $150.93M | $92.17M | $144.03M | $155.27M |
Total Liabilities | $20.27M | $23.94M | $56.23M | $22.99M |
Cash & Equivalents | $13.15M | $26.30M | $27.04M | $44.87M |
Free Cash Flow OCF − CapEx | $-38.33M | $-56.03M | $-45.82M | $-56.45M |
Shares Outstanding | 130.18M | 71.01M | 70.69M | 70.47M |